Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1482935

Cover Image

PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1482935

Multimodal Imaging Market - Global Outlook & Forecast 2024-2029

PUBLISHED:
PAGES: 341 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4200
PDF (5 User License)
USD 4999
PDF (Corporate User License)
USD 5999

Add to Cart

The global multimodal imaging market is expected to grow at a CAGR of 5.35% from 2023-2029.

MARKET TRENDS & DRIVERS

Growing Adoption of AI & Analytics in Diagnostic Imaging

The growing adoption of AI and analytics in diagnostic imaging undoubtedly creates exciting opportunities for the multimodal imaging market. By unlocking the power of complex data, AI has the potential to transform the way we diagnose and treat diseases, leading to improved patient outcomes and a more efficient healthcare system. However, navigating the ethical and regulatory landscape alongside ensuring responsible development will be critical in realizing the full potential of this transformative technology.

Multimodal Molecular Imaging in Drug Discovery and Development

The quest for faster, more efficient, and personalized drug development has led to the emergence of exciting new technologies. Among these, multimodal molecular imaging stands out as a game-changer, revolutionizing the way of visualizing and understanding diseases, ultimately shaping the future of pharmaceutical innovation, and paving the way for a booming multimodal imaging market. Multimodal imaging overcomes this limitation by seamlessly integrating data from multiple imaging modalities, such as PET, MRI, CT, and ultrasound, into a comprehensive picture.

Growing Geriatric Population & Subsequent Rise in Chronic Conditions

Multimodal imaging, the synergistic combination of two or more imaging modalities like PET, MRI, and CT, offers a multifaceted solution to the diagnostic challenges posed by chronic diseases in aging populations. Each modality provides a unique perspective, revealing anatomical structures and functional processes. The growing need for advanced diagnostics in the face of rising chronic disease prevalence among older adults propels the multimodal imaging market forward. Industry analysts anticipate a significant rise in market value.

Technological Advancements in Diagnostics Imaging Modalities

The healthcare landscape is witnessing a pivotal shift towards personalized medicine, demanding ever-more accurate and comprehensive diagnostic tools. The scope of multimodal imaging is where technological advancements in individual imaging modalities are shaping their markets and fueling the explosive growth of a combined force. Integrated scanners combining two or more modalities, like PET/CT or PET/MRI, offer one-stop solutions, streamlining workflows and reducing patient discomfort. Combining information from various modalities gives clinicians a more comprehensive view of disease, leading to earlier and more accurate diagnoses and ultimately improving patient outcomes.

Recent Developments & Partnerships in the Multimodal Imaging Industry

The multimodal imaging market, fueled by the convergence of diverse imaging modalities, is undergoing a period of rapid evolution. Recent developments and strategic partnerships are pushing the boundaries of technology and propelling the market toward broader adoption and impactful applications. Collaborations between pharmaceutical and imaging companies accelerate drug development by utilizing multimodal imaging for early disease detection, target validation, and therapy monitoring. Research institutions and industry players collaborate to translate innovative imaging technologies into clinical practice.

SEGMENTATION INSIGHTS

INSIGHTS BY TECHNOLOGY

The global multimodal imaging market is segmented based on technology into PET/CT, PET/MR, SPECT/CT, OCT/FMT, and others. The PET/CT accounted for the largest market in 2023. PET utilizes radiopharmaceuticals to detect metabolic activity within tissues, aiding in diagnosing and staging cancers, neurological disorders, and cardiovascular diseases. CT offers detailed anatomical information, facilitating the localization and characterization of abnormalities detected on PET scans. PET/CT is widely used in oncology for tumor detection, staging, treatment planning, and response assessment, as well as in cardiology and neurology.

PET/MR offers advantages over PET/CT, including improved soft tissue contrast, reduced radiation exposure, and potential synergistic effects between PET and MRI. PET/MR is utilized in oncology, neurology, and cardiology for applications such as tumor imaging, neurodegenerative disease assessment, and myocardial perfusion imaging. SPECT/CT integrates the functional imaging capabilities of SPECT with the anatomical imaging provided by CT. SPECT/CT is used in nuclear medicine for myocardial perfusion imaging, bone scans, thyroid imaging, and oncological applications. OCT/FMT is applied in ophthalmology for retinal imaging and angiography and in oncology for preclinical research and drug development.

Segmentation by Technology

  • PET/CT
  • PET/MR
  • SPECT/CT
  • OCT/FMT
  • Others

INSIGHTS BY APPLICATION

The global multimodal imaging market encompasses various diagnostic and clinical applications and applications in biomedical research. From brain & neurology and cardiology to oncology, ophthalmology, obstetrics and gynecology, and beyond, multimodal imaging is pivotal in advancing medical diagnostics, treatment planning, and research across various medical specialties.

Multimodal imaging techniques such as MRI, CT, PET, SPECT, and fMRI are used for the diagnosis and treatment planning of neurological disorders such as stroke, brain tumors, epilepsy, and neurodegenerative diseases. MRI, CT, ultrasound, and molecular imaging are also utilized to assess tumor microstructure, vascularity, and metabolism, guiding personalized treatment approaches and monitoring disease progression. In cardiology, multimodal imaging assesses cardiac structure, function, perfusion, and viability. Techniques such as PET/CT, PET/MRI, echocardiography, cardiac MRI, and coronary CT angiography are utilized to diagnose and manage cardiovascular diseases, including coronary artery disease, heart failure, valvular disorders, and cardiomyopathies.

Segmentation by Application

  • Diagnostic & Clinical
  • Brain & Neurology
  • Oncology
  • Cardiology
  • Ophthalmology
  • Others
  • Research

INSIGHTS BY END-USER

The global multimodal imaging market encompasses various end-users, including hospitals, diagnostic imaging centers, research institutions, and others. Each end-user segment contributes uniquely to the market's growth and evolution, fueling demand for advanced multimodal imaging technologies and applications across different medical diagnostics and research domains.

Hospitals represent the largest end-user segment in the global multimodal imaging market. These facilities utilize multimodal imaging systems for diagnostic and therapeutic applications across various medical specialties, including radiology, neurology, cardiology, oncology, ophthalmology, and orthopedics. Diagnostic imaging centers are specialized facilities that provide various imaging services to patients referred by healthcare providers. These centers offer advanced multimodal imaging techniques such as MRI, CT, PET, SPECT, ultrasound, and nuclear medicine imaging. Diagnostic imaging centers are vital in early disease detection, screening, and monitoring, serving as important end-users in the multimodal imaging market.

Segmentation by End-user

  • Hospitals
  • Diagnostic Imaging Centers
  • Academic & Research Centers
  • Others

GEOGRAPHICAL ANALYSIS

North America, particularly the US and Canada, dominates the global multimodal imaging market due to well-established healthcare infrastructure, high healthcare spending, and early adoption of advanced medical technologies. The presence of major multinational healthcare companies, research institutions, and academic centers drives innovation and market growth in this region. The demand for multimodal imaging in the region is fueled by the prevalence of chronic diseases, the aging population, an increasing emphasis on early disease detection, and personalized medicine.

Segmentation by Geography

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Netherlands
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa
    • UAE

COMPETITIVE LANDSCAPE

The global multimodal imaging market is a dynamic and fiercely competitive landscape driven by technological advancements, increasing demand for precise diagnostic solutions, and a growing emphasis on personalized healthcare. The global multimodal imaging market is dominated by several key players, each with a significant industry presence and a diverse portfolio of imaging solutions. Some of the leading players in the market include Canon Medical Systems, GE Healthcare, Koninklijke Philips, Siemens Healthineers, and Shimadzu Corporation. Furthermore, leading players invest heavily in research and development to drive innovation in multimodal imaging technologies. This includes developing advanced imaging systems with enhanced capabilities such as AI-driven image analysis, real-time image fusion, and 3D/4D imaging.

Key Company Profiles

  • Canon Medical Systems
  • GE Healthcare
  • Koninklijke Philips
  • Shimadzu Corporation
  • Siemens Healthineers

Other Prominent Vendors

  • Bruker
  • Mediso
  • MILabs B.V.
  • MinFound Medical Systems
  • MR Solution
  • Shanghai United Imaging Healthcare
  • SOFIE
  • Spectrum Dynamics Medical
  • Topcon

KEY QUESTIONS ANSWERED:

1.How big is the global multimodal imaging market?

2.What is the growth rate of the global multimodal imaging market?

3.Which region dominates the global multimodal imaging market share?

4.What are the significant trends in the global multimodal imaging market?

5.Who are the key players in the global multimodal imaging market?

Product Code: ARZ240503

TABLE OF CONTENTS

1. SCOPE & COVERAGE

  • 1.1. MARKET DEFINITION
    • 1.1.1. INCLUSIONS
    • 1.1.2. EXCLUSIONS
    • 1.1.3. MARKET ESTIMATION CAVEATS
  • 1.2. MARKET SEGMENTATION COVERAGE
    • 1.2.1. MARKET BY TECHNOLOGY
    • 1.2.2. MARKET BY APPLICATION
    • 1.2.3. MARKET BY END-USER
    • 1.2.4. REGIONS & COUNTRIES COVERED
  • 1.3. MARKET DERIVATION
    • 1.3.1. BASE YEAR

2. PREMIUM INSIGHTS

  • 2.1. OPPORTUNITY POCKETS
  • 2.2. OVERVIEW
    • 2.2.1. GEOGRAPHY INSIGHTS
    • 2.2.2. TECHNOLOGY INSIGHTS
    • 2.2.3. APPLICATION INSIGHTS
    • 2.2.4. END-USER INSIGHTS

3. MARKET AT A GLANCE

4. INTRODUCTION

  • 4.1. OVERVIEW

5. MARKET OPPORTUNITIES & TRENDS

  • 5.1. GROWING ADOPTION OF AI & ANALYTICS IN DIAGNOSTIC IMAGING
  • 5.2. MULTIMODAL MOLECULAR IMAGING IN DRUG DISCOVERY AND DEVELOPMENT
  • 5.3. AVAILABILITY OF REIMBURSEMENT AND INSURANCE COVERAGE FOR SCANS

6. MARKET GROWTH ENABLERS

  • 6.1. GROWING GERIATRIC POPULATION AND SUBSEQUENT RISE IN CHRONIC CONDITIONS
  • 6.2. TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTICS IMAGING MODALITIES
  • 6.3. RECENT DEVELOPMENTS & PARTNERSHIPS IN MULTIMODAL IMAGING INDUSTRY
  • 6.4. NON-INVASIVE IMAGING FUELING GROWTH IN NEUROSCIENCE & ONCOLOGY APPLICATION

7. MARKET RESTRAINTS

  • 7.1. HIGH OPERATING COST OF IMAGING SYSTEMS
  • 7.2. GROWING PREFERENCE FOR REFURBISHED EQUIPMENT
  • 7.3. LACK OF SKILLED PROFESSIONALS

8. MARKET LANDSCAPE

  • 8.1. MARKET OVERVIEW
  • 8.2. MARKET SIZE & FORECAST
  • 8.3. FIVE FORCES ANALYSIS
    • 8.3.1. THREAT OF NEW ENTRANTS
    • 8.3.2. BARGAINING POWER OF SUPPLIERS
    • 8.3.3. BARGAINING POWER OF BUYERS
    • 8.3.4. THREAT OF SUBSTITUTES
    • 8.3.5. COMPETITIVE RIVALRY

9. TECHNOLOGY

  • 9.1. MARKET SNAPSHOT & GROWTH ENGINE
  • 9.2. MARKET OVERVIEW
  • 9.3. PET/CT
    • 9.3.1. MARKET OVERVIEW
    • 9.3.2. MARKET SIZE & FORECAST
    • 9.3.3. PET/CT MARKET BY GEOGRAPHY
  • 9.4. PET/MR
    • 9.4.1. MARKET OVERVIEW
    • 9.4.2. MARKET SIZE & FORECAST
    • 9.4.3. PET/MR MARKET BY GEOGRAPHY
  • 9.5. SPECT/CT
    • 9.5.1. MARKET OVERVIEW
    • 9.5.2. MARKET SIZE & FORECAST
    • 9.5.3. SPECT/CT MARKET BY GEOGRAPHY
  • 9.6. OCT/FMT
    • 9.6.1. MARKET OVERVIEW
    • 9.6.2. MARKET SIZE & FORECAST
    • 9.6.3. OCT/FMT MARKET BY GEOGRAPHY
  • 9.7. OTHERS
    • 9.7.1. MARKET OVERVIEW
    • 9.7.2. MARKET SIZE & FORECAST
    • 9.7.3. OTHERS MARKET BY GEOGRAPHY

10. APPLICATION

  • 10.1. MARKET SNAPSHOT & GROWTH ENGINE
  • 10.2. MARKET OVERVIEW
  • 10.3. DIAGNOSTIC & CLINICAL
    • 10.3.1. MARKET OVERVIEW
    • 10.3.2. MARKET SIZE & FORECAST
    • 10.3.3. DIAGNOSTIC & CLINICAL MARKET BY GEOGRAPHY
  • 10.4. RESEARCH
    • 10.4.1. MARKET OVERVIEW
    • 10.4.2. MARKET SIZE & FORECAST
    • 10.4.3. RESEARCH MARKET BY GEOGRAPHY

11. END-USER

  • 11.1. MARKET SNAPSHOT & GROWTH ENGINE
  • 11.2. MARKET OVERVIEW
  • 11.3. HOSPITALS
    • 11.3.1. MARKET OVERVIEW
    • 11.3.2. MARKET SIZE & FORECAST
    • 11.3.3. HOSPITALS MARKET BY GEOGRAPHY
  • 11.4. DIAGNOSTIC IMAGING CENTERS
    • 11.4.1. MARKET OVERVIEW
    • 11.4.2. MARKET SIZE & FORECAST
    • 11.4.3. DIAGNOSTIC IMAGING CENTERS MARKET BY GEOGRAPHY
  • 11.5. ACADEMIC & RESEARCH CENTERS
    • 11.5.1. MARKET OVERVIEW
    • 11.5.2. MARKET SIZE & FORECAST
    • 11.5.3. ACADEMIC & RESEARCH CENTERS MARKET BY GEOGRAPHY
  • 11.6. OTHERS
    • 11.6.1. MARKET OVERVIEW
    • 11.6.2. MARKET SIZE & FORECAST
    • 11.6.3. OTHERS MARKET BY GEOGRAPHY

12. GEOGRAPHY

  • 12.1. MARKET SNAPSHOT & GROWTH ENGINE
  • 12.2. GEOGRAPHIC OVERVIEW

13. NORTH AMERICA

  • 13.1. MARKET OVERVIEW
  • 13.2. MARKET SIZE & FORECAST
    • 13.2.1. NORTH AMERICA MARKET BY TECHNOLOGY
    • 13.2.2. NORTH AMERICA MARKET BY APPLICATION
    • 13.2.3. NORTH AMERICA MARKET BY END-USER
  • 13.3. KEY COUNTRIES
    • 13.3.1. US: MARKET SIZE & FORECAST
    • 13.3.2. CANADA: MARKET SIZE & FORECAST

14. EUROPE

  • 14.1. MARKET OVERVIEW
  • 14.2. MARKET SIZE & FORECAST
    • 14.2.1. EUROPE MARKET BY TECHNOLOGY
    • 14.2.2. EUROPE MARKET BY APPLICATION
    • 14.2.3. EUROPE MARKET BY END-USER
  • 14.3. KEY COUNTRIES
    • 14.3.1. GERMANY: MARKET SIZE & FORECAST
    • 14.3.2. FRANCE: MARKET SIZE & FORECAST
    • 14.3.3. UK: MARKET SIZE & FORECAST
    • 14.3.4. ITALY: MARKET SIZE & FORECAST
    • 14.3.5. SPAIN: MARKET SIZE & FORECAST
    • 14.3.6. RUSSIA: MARKET SIZE & FORECAST
    • 14.3.7. NETHERLANDS: MARKET SIZE & FORECAST

15. APAC

  • 15.1. MARKET OVERVIEW
  • 15.2. MARKET SIZE & FORECAST
    • 15.2.1. APAC MARKET BY TECHNOLOGY
    • 15.2.2. APAC MARKET BY APPLICATION
    • 15.2.3. APAC MARKET BY END-USER
  • 15.3. KEY COUNTRIES
    • 15.3.1. CHINA: MARKET SIZE & FORECAST
    • 15.3.2. JAPAN: MARKET SIZE & FORECAST
    • 15.3.3. INDIA: MARKET SIZE & FORECAST
    • 15.3.4. SOUTH KOREA: MARKET SIZE & FORECAST
    • 15.3.5. AUSTRALIA: MARKET SIZE & FORECAST

16. LATIN AMERICA

  • 16.1. MARKET OVERVIEW
  • 16.2. MARKET SIZE & FORECAST
    • 16.2.1. LATIN AMERICA MARKET BY TECHNOLOGY
    • 16.2.2. LATIN AMERICA MARKET BY APPLICATION
    • 16.2.3. LATIN AMERICA MARKET BY END-USER
  • 16.3. KEY COUNTRIES
    • 16.3.1. BRAZIL: MARKET SIZE & FORECAST
    • 16.3.2. MEXICO: MARKET SIZE & FORECAST
    • 16.3.3. ARGENTINA: MARKET SIZE & FORECAST
    • 16.3.4. COLOMBIA: MARKET SIZE & FORECAST

17. MIDDLE EAST & AFRICA

  • 17.1. MARKET OVERVIEW
  • 17.2. MARKET SIZE & FORECAST
    • 17.2.1. MIDDLE EAST & AFRICA MARKET BY TECHNOLOGY
    • 17.2.2. MIDDLE EAST & AFRICA MARKET BY APPLICATION
    • 17.2.3. MIDDLE EAST & AFRICA MARKET BY END-USER
  • 17.3. KEY COUNTRIES
    • 17.3.1. TURKEY: MARKET SIZE & FORECAST
    • 17.3.2. SAUDI ARABIA: MARKET SIZE & FORECAST
    • 17.3.3. SOUTH AFRICA: MARKET SIZE & FORECAST
    • 17.3.4. UAE: MARKET SIZE & FORECAST

18. COMPETITIVE LANDSCAPE

  • 18.1. COMPETITION OVERVIEW
  • 18.2. MARKET SHARE ANALYSIS
    • 18.2.1. CANON MEDICAL SYSTEMS
    • 18.2.2. GE HEALTHCARE
    • 18.2.3. KONINKLIJKE PHILIPS
    • 18.2.4. SHIMADZU CORPORATION
    • 18.2.5. SIEMENS HEALTHINEERS

19. KEY COMPANY PROFILES

  • 19.1. CANON MEDICAL SYSTEMS
    • 19.1.1. BUSINESS OVERVIEW
    • 19.1.2. PRODUCT OFFERINGS
    • 19.1.3. KEY STRATEGIES
    • 19.1.4. KEY STRENGTHS
    • 19.1.5. KEY OPPORTUNITIES
  • 19.2. GE HEALTHCARE
    • 19.2.1. BUSINESS OVERVIEW
    • 19.2.2. PRODUCT OFFERINGS
    • 19.2.3. KEY STRATEGIES
    • 19.2.4. KEY STRENGTHS
    • 19.2.5. KEY OPPORTUNITIES
  • 19.3. KONINKLIJKE PHILIPS
    • 19.3.1. BUSINESS OVERVIEW
    • 19.3.2. PRODUCT OFFERINGS
    • 19.3.3. KEY STRATEGIES
    • 19.3.4. KEY STRENGTHS
    • 19.3.5. KEY OPPORTUNITIES
  • 19.4. SHIMADZU CORPORATION
    • 19.4.1. BUSINESS OVERVIEW
    • 19.4.2. PRODUCT OFFERINGS
    • 19.4.3. KEY STRATEGIES
    • 19.4.4. KEY STRENGTHS
    • 19.4.5. KEY OPPORTUNITIES
  • 19.5. SIEMENS HEALTHINEERS
    • 19.5.1. BUSINESS OVERVIEW
    • 19.5.2. PRODUCT OFFERINGS
    • 19.5.3. KEY STRATEGIES
    • 19.5.4. KEY STRENGTHS
    • 19.5.5. KEY OPPORTUNITIES

20. OTHER PROMINENT VENDORS

  • 20.1. BRUKER
    • 20.1.1. BUSINESS OVERVIEW
    • 20.1.2. PRODUCT OFFERINGS
  • 20.2. MEDISO
    • 20.2.1. BUSINESS OVERVIEW
    • 20.2.2. PRODUCT OFFERINGS
  • 20.3. MILABS B.V.
    • 20.3.1. BUSINESS OVERVIEW
    • 20.3.2. PRODUCT OFFERINGS
  • 20.4. MINFOUND MEDICAL SYSTEMS
    • 20.4.1. BUSINESS OVERVIEW
    • 20.4.2. PRODUCT OFFERINGS
  • 20.5. MR SOLUTION
    • 20.5.1. BUSINESS OVERVIEW
    • 20.5.2. PRODUCT OFFERINGS
  • 20.6. SHANGHAI UNITED IMAGING HEALTHCARE
    • 20.6.1. BUSINESS OVERVIEW
    • 20.6.2. PRODUCT OFFERINGS
  • 20.7. SOFIE
    • 20.7.1. BUSINESS OVERVIEW
    • 20.7.2. PRODUCT OFFERINGS
  • 20.8. SPECTRUM DYNAMICS MEDICAL
    • 20.8.1. BUSINESS OVERVIEW
    • 20.8.2. PRODUCT OFFERINGS
  • 20.9. TOPCON
    • 20.9.1. BUSINESS OVERVIEW
    • 20.9.2. PRODUCT OFFERINGS

21. REPORT SUMMARY

  • 21.1. KEY TAKEAWAYS
  • 21.2. STRATEGIC RECOMMENDATIONS

22. QUANTITATIVE SUMMARY

  • 22.1. MARKET BY TECHNOLOGY
    • 22.1.1. NORTH AMERICA MARKET BY TECHNOLOGY
    • 22.1.2. EUROPE MARKET BY TECHNOLOGY
    • 22.1.3. APAC MARKET BY TECHNOLOGY
    • 22.1.4. LATIN AMERICA MARKET BY TECHNOLOGY
    • 22.1.5. MIDDLE EAST & AFRICA MARKET BY TECHNOLOGY
  • 22.2. MARKET BY APPLICATION
    • 22.2.1. NORTH AMERICA MARKET BY APPLICATION
    • 22.2.2. EUROPE MARKET BY APPLICATION
    • 22.2.3. APAC MARKET BY APPLICATION
    • 22.2.4. LATIN AMERICA MARKET BY APPLICATION
    • 22.2.5. MIDDLE EAST & AFRICA MARKET BY APPLICATION
  • 22.3. MARKET BY END-USER
    • 22.3.1. NORTH AMERICA MARKET BY END-USER
    • 22.3.2. EUROPE MARKET BY END-USER
    • 22.3.3. APAC MARKET BY END-USER
    • 22.3.4. LATIN AMERICA MARKET BY END-USER
    • 22.3.5. MIDDLE EAST & AFRICA MARKET BY END-USER
  • 22.4. MARKET BY GEOGRAPHY
    • 22.4.1. PET/CT MARKET BY GEOGRAPHY
    • 22.4.2. PET/MR MARKET BY GEOGRAPHY
    • 22.4.3. SPECT/CT MARKET BY GEOGRAPHY
    • 22.4.4. OCT/FMT MARKET BY GEOGRAPHY
    • 22.4.5. OTHERS MARKET BY GEOGRAPHY
    • 22.4.6. DIAGNOSTIC & CLINICAL MARKET BY GEOGRAPHY
    • 22.4.7. RESEARCH MARKET BY GEOGRAPHY
    • 22.4.8. HOSPITALS MARKET BY GEOGRAPHY
    • 22.4.9. DIAGNOSTIC IMAGING CENTERS MARKET BY GEOGRAPHY
    • 22.4.10. ACADEMIC & RESEARCH CENTERS MARKET BY GEOGRAPHY
    • 22.4.11. OTHERS MARKET BY GEOGRAPHY

23. APPENDIX

  • 23.1. RESEARCH METHODOLOGY
  • 23.2. RESEARCH PROCESS
  • 23.3. REPORT ASSUMPTIONS & CAVEATS
    • 23.3.1. KEY CAVEATS
    • 23.3.2. CURRENCY CONVERSION
  • 23.4. ABBREVIATIONS
Product Code: ARZ240503

List Of Exhibits

LIST OF EXHIBITS

  • EXHIBIT 1 MARKET SIZE CALCULATION APPROACH 2023
  • EXHIBIT 2 GLOBAL MULTIMODAL IMAGING MARKET BY GEOGRAPHY: MARKET SHARE 2023 & 2029 (%)
  • EXHIBIT 3 GLOBAL MULTIMODAL IMAGING MARKET BY TECHNOLOGY: MARKET SHARE 2023 & 2029 (%)
  • EXHIBIT 4 GLOBAL MULTIMODAL IMAGING MARKET BY APPLICATION: MARKET SHARE 2023 & 2029 (%)
  • EXHIBIT 5 GLOBAL MULTIMODAL IMAGING MARKET BY END-USER: MARKET SHARE 2023 & 2029 (%)
  • EXHIBIT 6 IMPACT OF GROWING ADOPTION OF AI & ANALYTICS IN DIAGNOSTIC IMAGING
  • EXHIBIT 7 IMPACT OF MULTIMODAL MOLECULAR IMAGING IN DRUG DISCOVERY AND DEVELOPMENT
  • EXHIBIT 8 APPLICATIONS OF MULTIMODAL IMAGING ACROSS THE STAGES OF DRUG DISCOVERY & DEVELOPMENT
  • EXHIBIT 9 IMPACT OF AVAILABILITY OF REIMBURSEMENT AND INSURANCE COVERAGE FOR SCANS
  • EXHIBIT 10 IMPACT OF GROWING GERIATRIC POPULATION AND SUBSEQUENT RISE IN CHRONIC CONDITIONS
  • EXHIBIT 11 IMPACT OF TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTICS IMAGING MODALITIES
  • EXHIBIT 12 IMPACT OF RECENT DEVELOPMENTS & PARTNERSHIPS IN MULTIMODAL IMAGING INDUSTRY
  • EXHIBIT 13 IMPACT OF NON-INVASIVE IMAGING FUELING GROWTH IN NEUROSCIENCE & ONCOLOGY APPLICATION
  • EXHIBIT 14 IMPACT OF HIGH OPERATING COST OF IMAGING SYSTEMS
  • EXHIBIT 15 IMPACT OF GROWING PREFERENCE FOR REFURBISHED EQUIPMENT
  • EXHIBIT 16 IMPACT OF LACK OF SKILLED PROFESSIONALS
  • EXHIBIT 17 GLOBAL MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 18 FIVE FORCES ANALYSIS 2023
  • EXHIBIT 19 INCREMENTAL GROWTH BY TECHNOLOGY 2023 & 2029
  • EXHIBIT 20 GLOBAL MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029: INCREMENTAL GROWTH ($ MILLION)
  • EXHIBIT 21 GLOBAL MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029: ABSOLUTE GROWTH (%)
  • EXHIBIT 22 GLOBAL PET/CT MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 23 GLOBAL PET/CT MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 24 GLOBAL PET/MR MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 25 GLOBAL PET/MR MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 26 GLOBAL SPECT/CT MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 27 GLOBAL SPECT/CT MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 28 GLOBAL OCT/FMT MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 29 GLOBAL OCT/FMT MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 30 GLOBAL OTHERS MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 31 GLOBAL OTHERS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 32 INCREMENTAL GROWTH BY APPLICATION 2023 & 2029
  • EXHIBIT 33 GLOBAL MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029: INCREMENTAL GROWTH ($ MILLION)
  • EXHIBIT 34 GLOBAL MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029: ABSOLUTE GROWTH (%)
  • EXHIBIT 35 GLOBAL DIAGNOSTIC & CLINICAL MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 36 GLOBAL BRAIN & NEUROLOGY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 37 GLOBAL ONCOLOGY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 38 GLOBAL CARDIOLOGY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 39 GLOBAL OPHTHALMOLOGY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 40 GLOBAL OTHERS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 41 GLOBAL DIAGNOSTIC & CLINICAL MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 42 GLOBAL RESEARCH MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 43 GLOBAL RESEARCH MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 44 INCREMENTAL GROWTH BY END-USER 2023 & 2029
  • EXHIBIT 45 GLOBAL MULTIMODAL IMAGING MARKET BY END-USER 2023-2029: INCREMENTAL GROWTH ($ MILLION)
  • EXHIBIT 46 GLOBAL MULTIMODAL IMAGING MARKET BY END-USER 2023-2029: ABSOLUTE GROWTH (%)
  • EXHIBIT 47 GLOBAL HOSPITALS MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 48 GLOBAL HOSPITALS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 49 GLOBAL DIAGNOSTIC CENTERS MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 50 GLOBAL DIAGNOSTIC CENTERS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 51 GLOBAL ACADEMIC & RESEARCH CENTERS MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 52 GLOBAL ACADEMIC & RESEARCH CENTERS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 53 GLOBAL OTHERS MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 54 GLOBAL OTHERS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 55 INCREMENTAL GROWTH BY GEOGRAPHY 2023 & 2029
  • EXHIBIT 56 GLOBAL MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029: INCREMENTAL GROWTH ($ MILLION)
  • EXHIBIT 57 GLOBAL MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029: ABSOLUTE GROWTH (%)
  • EXHIBIT 58 NORTH AMERICA MULTIMODAL IMAGING MARKET: MAJOR COUNTRIES BY REVENUE IN 2023 ($ MILLION)
  • EXHIBIT 59 NORTH AMERICA MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 60 NORTH AMERICA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 61 INCREMENTAL GROWTH IN NORTH AMERICA 2023 & 2029
  • EXHIBIT 62 US MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 63 CANADA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 64 EUROPE MULTIMODAL IMAGING MARKET: MAJOR COUNTRIES BY REVENUE IN 2023 ($ MILLION)
  • EXHIBIT 65 EUROPE MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 66 EUROPE MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 67 INCREMENTAL GROWTH IN EUROPE 2023 & 2029
  • EXHIBIT 68 GERMANY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 69 FRANCE MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 70 UK MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 71 ITALY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 72 SPAIN MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 73 RUSSIA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 74 NETHERLANDS MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 75 APAC MULTIMODAL IMAGING MARKET: MAJOR COUNTRIES BY REVENUE IN 2023 ($ MILLION)
  • EXHIBIT 76 APAC MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 77 APAC MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 78 INCREMENTAL GROWTH IN APAC 2023 & 2029
  • EXHIBIT 79 CHINA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 80 JAPAN MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 81 INDIA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 82 SOUTH KOREA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 83 AUSTRALIA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 84 LATIN AMERICA MULTIMODAL IMAGING MARKET: MAJOR COUNTRIES BY REVENUE IN 2023 ($ MILLION)
  • EXHIBIT 85 LATIN AMERICA MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 86 LATIN AMERICA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 87 INCREMENTAL GROWTH IN LATIN AMERICA 2023 & 2029
  • EXHIBIT 88 BRAZIL MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 89 MEXICO MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 90 ARGENTINA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 91 COLOMBIA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 92 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET: MAJOR COUNTRIES BY REVENUE IN 2023 ($ MILLION)
  • EXHIBIT 93 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 94 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 95 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2023 & 2029
  • EXHIBIT 96 TURKEY MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 97 SAUDI ARABIA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 98 SOUTH AFRICA MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 99 UAE MULTIMODAL IMAGING MARKET 2020-2029 ($ MILLION)
  • EXHIBIT 100 VENDORS OFFERING MULTIMODAL IMAGING PRODUCTS: MARKET DOMINANCE ANALYSIS
  • EXHIBIT 101 VENDORS OFFERING COMMERCIAL MULTIMODAL IMAGING PRODUCTS: CAPABILITIES & EXPERTISE ASSESSMENT
  • EXHIBIT 102 KEY CAVEATS

List Of Tables

LIST OF TABLES

  • TABLE 1 GLOBAL PET/CT MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 2 GLOBAL PET/CT MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 3 GLOBAL PET/MR MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 4 GLOBAL PET/MR MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 5 GLOBAL SPECT/CT MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 6 GLOBAL SPECT/CT MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 7 GLOBAL OCT/FMT MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 8 GLOBAL OCT/FMT MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 9 GLOBAL OTHERS MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 10 GLOBAL OTHERS MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 11 GLOBAL DIAGNOSTIC & CLINICAL MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 12 GLOBAL DIAGNOSTIC & CLINICAL MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 13 GLOBAL RESEARCH MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 14 GLOBAL RESEARCH MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 15 GLOBAL HOSPITALS MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 16 GLOBAL HOSPITALS MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 17 GLOBAL DIAGNOSTIC CENTERS MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 18 GLOBAL DIAGNOSTIC CENTERS MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 19 GLOBAL ACADEMIC & RESEARCH CENTERS MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 20 GLOBAL ACADEMIC & RESEARCH CENTERS MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 21 GLOBAL OTHERS MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 22 GLOBAL OTHERS MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 23 NORTH AMERICA MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 ($ MILLION)
  • TABLE 24 NORTH AMERICA MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 (%)
  • TABLE 25 NORTH AMERICA MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 26 NORTH AMERICA MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 27 NORTH AMERICA MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 28 NORTH AMERICA MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 (%)
  • TABLE 29 EUROPE MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 ($ MILLION)
  • TABLE 30 EUROPE MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 (%)
  • TABLE 31 EUROPE MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 32 EUROPE MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 33 EUROPE MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 34 EUROPE MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 (%)
  • TABLE 35 APAC MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 ($ MILLION)
  • TABLE 36 APAC MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 (%)
  • TABLE 37 APAC MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 38 APAC MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 39 APAC MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 40 APAC MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 (%)
  • TABLE 41 LATIN AMERICA MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 ($ MILLION)
  • TABLE 42 LATIN AMERICA MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 (%)
  • TABLE 43 LATIN AMERICA MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 44 LATIN AMERICA MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 45 LATIN AMERICA MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 46 LATIN AMERICA MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 (%)
  • TABLE 47 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 ($ MILLION)
  • TABLE 48 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 (%)
  • TABLE 49 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 50 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 51 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 52 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 (%)
  • TABLE 53 CANON MEDICAL SYSTEMS: MAJOR PRODUCT OFFERINGS
  • TABLE 54 GE HEALTHCARE: MAJOR PRODUCT OFFERINGS
  • TABLE 55 KONINKLIJKE PHILIPS: MAJOR PRODUCT OFFERINGS
  • TABLE 56 SHIMADZU CORPORATION: MAJOR PRODUCT OFFERINGS
  • TABLE 57 SIEMENS HEALTHINEERS: MAJOR PRODUCT OFFERINGS
  • TABLE 58 BRUKER: MAJOR PRODUCT OFFERINGS
  • TABLE 59 MEDISO: MAJOR PRODUCT OFFERINGS
  • TABLE 60 MILABS B.V.: MAJOR PRODUCT OFFERINGS
  • TABLE 61 MINFOUND MEDICAL SYSTEMS: MAJOR PRODUCT OFFERINGS
  • TABLE 62 MR SOLUTION: MAJOR PRODUCT OFFERINGS
  • TABLE 63 SHANGHAI UNITED IMAGING HEALTHCARE: MAJOR PRODUCT OFFERINGS
  • TABLE 64 SOFIE: MAJOR PRODUCT OFFERINGS
  • TABLE 65 SPECTRUM DYNAMICS MEDICAL: MAJOR PRODUCT OFFERINGS
  • TABLE 66 TOPCON: MAJOR PRODUCT OFFERINGS
  • TABLE 67 GLOBAL MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 ($ MILLION)
  • TABLE 68 GLOBAL MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 (%)
  • TABLE 69 NORTH AMERICA MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 ($ MILLION)
  • TABLE 70 NORTH AMERICA MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 (%)
  • TABLE 71 EUROPE MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 ($ MILLION)
  • TABLE 72 EUROPE MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 (%)
  • TABLE 73 APAC MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 ($ MILLION)
  • TABLE 74 APAC MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 (%)
  • TABLE 75 LATIN AMERICA MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 ($ MILLION)
  • TABLE 76 LATIN AMERICA MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 (%)
  • TABLE 77 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 ($ MILLION)
  • TABLE 78 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET BY TECHNOLOGY 2023-2029 (%)
  • TABLE 79 GLOBAL MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 80 GLOBAL MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 81 NORTH AMERICA MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 82 NORTH AMERICA MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 83 EUROPE MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 84 EUROPE MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 85 APAC MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 86 APAC MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 87 LATIN AMERICA MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 88 LATIN AMERICA MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 89 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 ($ MILLION)
  • TABLE 90 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET BY APPLICATION 2023-2029 (%)
  • TABLE 91 GLOBAL MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 92 GLOBAL MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 (%)
  • TABLE 93 NORTH AMERICA MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 94 NORTH AMERICA MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 (%)
  • TABLE 95 EUROPE MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 96 EUROPE MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 (%)
  • TABLE 97 APAC MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 98 APAC MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 (%)
  • TABLE 99 LATIN AMERICA MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 100 LATIN AMERICA MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 (%)
  • TABLE 101 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 ($ MILLION)
  • TABLE 102 MIDDLE EAST & AFRICA MULTIMODAL IMAGING MARKET BY END-USER 2023-2029 (%)
  • TABLE 103 GLOBAL MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 104 GLOBAL MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 105 GLOBAL PET/CT MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 106 GLOBAL PET/CT MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 107 GLOBAL PET/MR MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 108 GLOBAL PET/MR MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 109 GLOBAL SPECT/CT MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 110 GLOBAL SPECT/CT MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 111 GLOBAL OCT/FMT MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 112 GLOBAL OCT/FMT MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 113 GLOBAL OTHERS MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 114 GLOBAL OTHERS MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 115 GLOBAL DIAGNOSTIC & CLINICAL MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 116 GLOBAL DIAGNOSTIC & CLINICAL MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 117 GLOBAL RESEARCH MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 118 GLOBAL RESEARCH MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 119 GLOBAL HOSPITALS MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 120 GLOBAL HOSPITALS MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 121 GLOBAL DIAGNOSTIC CENTER MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 122 GLOBAL DIAGNOSTIC CENTER MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 123 GLOBAL ACADEMIC & RESEARCH CENTER MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 124 GLOBAL ACADEMIC & RESEARCH CENTER MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 125 GLOBAL OTHERS MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 ($ MILLION)
  • TABLE 126 GLOBAL OTHERS MULTIMODAL IMAGING MARKET BY GEOGRAPHY 2023-2029 (%)
  • TABLE 127 CURRENCY CONVERSION 2016-2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!